Microbiome and Infectious Disease (MaID) Innovation Hub
Liverpool City Region Life Sciences Innovation Zone Project.
The Microbiome and Infectious Disease (MaID) Innovation Hub will drive development and commercialisation of microbiome therapies, novel antimicrobials and diagnostics for infectious disease.
Microbiomes - communities of microorganisms - offer a new frontier in tackling infectious disease, cancer, inflammatory bowel disease and mental health. They are also an important source of novel antimicrobials such as bacteriophage that can act as alternatives to antibiotics and help to tackle global antimicrobial resistance (AMR).
MaID will harness the world-leading expertise of the Microbiome Innovation Centre (MIC), and Liverpool Science Park-based High Value Manufacturing Catapult CPI, to provide end-to-end support for businesses and organisations seeking to de-risk and to accelerate microbiome and phage therapeutics to market.
Through scientific consultancy, access to cutting-edge technology, a strong partnership network and a rich range of guidance relating to funding, regulatory, IP, manufacturing and more, MaID will position Liverpool as the place where life science innovators thrive.
The Liverpool City Region Life Sciences Innovation Zone Programme forms part of the Government’s national Investment Zone Programme, positioning the city region as a powerhouse for health and life sciences innovation.